Home Stock

Stock Research: Johnson & Johnson

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Johnson & Johnson

NYQ:JNJ US4781601046
84
  • Value
    73
  • Growth
    72
  • Safety
    Safety
    61
  • Combined
    88
  • Sentiment
    45
  • 360° View
    360° View
    84
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Johnson & Johnson researches, develops, manufactures, and sells healthcare products. It operates in the healthcare field through two segments: Innovative Medicine and MedTech. Medicines are distributed worldwide. In the last fiscal year, the company had a market cap of $373,350 million, profits of $61,385 million, revenue of $88,821 million, and 138,100 employees.

more

ANALYSIS: With an Obermatt 360° View of 84 (better than 84% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Johnson & Johnson are very positive. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Johnson & Johnson. The consolidated Value Rank has an attractive rank of 73, which means that the share price of Johnson & Johnson is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 73% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 72, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 61. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 45. Professional investors are more confident in 55% other stocks. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Profit Growth
Country USA
Industry Pharmaceuticals
Size Medium
Website jnj.com
Index
Dow Jones
D.J. US Health Care
D.J. US Pharmaceutical
S&P 500
Johnson & Johnson stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
73 51 60 65
Growth
72 41 25 51
Safety
Safety
61 56 73 72
Sentiment
45 54 10 75
360° View
360° View
84 43 27 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
7 26 17 38
Opinions Change
50 50 6 66
Pro Holdings
n/a 94 76 36
Market Pulse
88 37 26 86
Sentiment
45 54 10 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
73 51 60 65
Growth
72 41 25 51
Safety Safety
61 56 73 72
Combined
88 45 56 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
49 24 20 20
Price vs. Earnings (P/E)
24 48 54 58
Price vs. Book (P/B)
14 12 18 20
Dividend Yield
99 94 96 96
Value
73 51 60 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
53 33 34 27
Profit Growth
100 35 46 66
Capital Growth
19 58 23 42
Stock Returns
62 51 49 75
Growth
72 41 25 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
29 51 55 67
Refinancing
37 12 21 13
Liquidity
90 96 98 96
Safety Safety
61 56 73 72

Similar Stocks

Discover high‑ranked alternatives to Johnson & Johnson and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

M/I Homes

NYQ:MHO
Country: USA
Industry: Homebuilding
Size: Medium
Full Stock Analysis

Phibro Animal Health

NMQ:PAHC
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Innoviva

NSQ:INVA
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews